potential

Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241

PFL-721 and PFL-241 are mutant-specific EGFR inhibitors with best-in-class potential, being developed as treatment options for emergent and unmet medical…

6 months ago

Investigational combination of first-in-class bispecific antibodies TALVEY (talquetamab) and TECVAYLI (teclistamab) shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of…

6 months ago

Green Fertilizer Made with Air and Plasma: NitroCapt (Sweden) wins $2M Food Planet Prize 2025 for developing low-emission fertilizers

STOCKHOLM, June 13, 2025 /PRNewswire/ -- The Curt Bergfors Foundation is honored to announce that NitroCapt was awarded the Food Planet…

6 months ago

ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy

VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal…

7 months ago

Alghanim Industries Brings Starlink’s Groundbreaking Satellite Internet to Global Markets

To drive innovation, Alghanim Industries is unveiling Sama X, a bold new tech venture and authorized Starlink global reseller that brings…

7 months ago

The Brain Prize: HM The King of Denmark presents prestigious prize to US and German scientists for seminal discoveries in brain cancer

Two pioneering scientists received The Brain Prize 2025 for their discoveries that open an entirely new way of thinking about…

7 months ago
Show previous Posts